Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Osteochondrosis

ClinicalTrials.gov lists 29 trials for Osteochondrosis or a narrower condition beneath it.

MeSH D055034 Musculoskeletal Diseases C05 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1/2 Phase 1/2 1 Not applicable Not applicable 16 Observational Observational 12 Phase 1/2 Phase 1/2 1 Not applicable Not applicable 16 Observational Observational 12

Trials per phase

15 of the 29 trials are tagged with Osteochondrosis itself; the rest are tagged with a narrower condition beneath it.

Get the Osteochondrosis report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Osteochondrosis trials start? (15)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1/2
  • Not applicable
  • Observational

Top of scale: 4

2006: 2 trials (Observational 1, Phase 1/2 1) 2010: 1 trials (Observational 1) 2014: 1 trials (Observational 1) 2015: 1 trials (Not applicable 1) 2016: 1 trials (Not applicable 1) 2017: 1 trials (Not applicable 1) 2018: 2 trials (Observational 2) 2019: 1 trials (Observational 1) 2020: 2 trials (Observational 1, Not applicable 1) 2021: 2 trials (Observational 2) 2022: 2 trials (Not applicable 2) 2023: 2 trials (Observational 1, Not applicable 1) 2024: 1 trials (Observational 1) 2025: 4 trials (Not applicable 4)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 6
2025 4
2024 1
2023 2
2022 2
2021 2
2020 2
2019 1
2018 2
2017 1

No forecast is made for this condition: it averages 3.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Osteochondrosis trials in? (3)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1/2 1
Not applicable 16
Observational 12

How many Osteochondrosis trials are recruiting? (6)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 3
Recruiting 5
Active, not recruiting 1
Completed 14
Withdrawn 2

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which drugs are being tested for Osteochondrosis? (1)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
Calcium/Vitamin D 1

Interventions as named in the registry (3)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
usual care treatment 1
Resting conditions 1
L:Lidocaine 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which publications cover Osteochondrosis? (14)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Long-Term Knee Health in Adults with a History of Adolescent Osgood-Schlatter: A National Cohort Study of Patients in Secondary Care in Denmark 1977-2020. Sports medicine (Auckland, N.Z.) 2025 Yes
Incidence and management of Osgood-Schlatter disease in general practice: retrospective cohort study. The British journal of general practice : the journal of the Royal College of General Practitioners 2022 Yes
A systematic review on conservative treatment options for OSGOOD-Schlatter disease. Physical therapy in sport : official journal of the Association of Chartered Physiotherapists in Sports Medicine 2021 Yes
Conservative treatment of Osgood-Schlatter disease among young professional soccer players. International orthopaedics 2020 Yes
Current management strategies in Osgood Schlatter: A cross-sectional mixed-method study. Scandinavian journal of medicine & science in sports 2020 Yes

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Osteochondrosis 399319 Exact Orphanet Rare Disease Ontology (ORDO)
Osteochondrosis 399319 Exact Orphadata Science knowledge files, Product 1

Sub-conditions in MeSH (1)

MeSH descendants one level down with at least one trial, most trials first.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, and prevalence.

Browse all condition evidence pages